Back
Zevra Therapeutics Vs. Xeris Biopharma Holdings Industry Stock Comparison
Buy
67
ZVRA
Zevra Therapeutics
Last Price:
9.63
Seasonality Move:
6.65%
Buy
83
XERS
Xeris Biopharma Holdings
Last Price:
3.09
Seasonality Move:
-0.27%
Buy
67
Zevra Therapeutics (ZVRA)
is a Buy
Is Zevra Therapeutics a Buy, Sell or Hold?
- The current Zevra Therapeutics [ZVRA] share price is $9.13. The Score for ZVRA is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- ZVRA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
83
Xeris Biopharma Holdings (XERS)
is a Buy
Is Xeris Biopharma Holdings a Buy, Sell or Hold?
- The current Xeris Biopharma Holdings [XERS] share price is $3.04. The Score for XERS is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- XERS is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
ZVRA Stock Price Chart
What is Zevra Therapeutics's stock price today?
-
The Zevra Therapeutics share price today is $9.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ZVRA is experiencing slight buying pressure.
XERS Stock Price Chart
What is Xeris Biopharma Holdings's stock price today?
-
The Xeris Biopharma Holdings share price today is $3.04
The current trend is relatively stagnant and XERS is experiencing selling pressure, which indicates risk of future bearish movement.
ZVRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.24 | Buy |
Relative Strength Index (14 RSI): | 61.61 | Buy |
Chaikin Money Flow: | 68733 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.17 - 8.91) | Buy |
Bollinger Bands (100): | (6.37 - 8.45) | Buy |
XERS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 46.54 | Sell |
Chaikin Money Flow: | -1008304 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.02 - 3.3) | Sell |
Bollinger Bands (100): | (2.44 - 3.1) | Buy |
ZVRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.82 | Buy |
20-day SMA: | 8.62 | Buy |
50-day SMA: | 8.15 | Buy |
200-day SMA: | 6.34 | Buy |
8-day EMA: | 8.88 | Buy |
20-day EMA: | 8.66 | Buy |
50-day EMA: | 8.18 | Buy |
200-day EMA: | 6.74 | Buy |
XERS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.04 | Buy |
20-day SMA: | 3.18 | Sell |
50-day SMA: | 3.03 | Buy |
200-day SMA: | 2.5 | Buy |
8-day EMA: | 3.06 | Sell |
20-day EMA: | 3.11 | Sell |
50-day EMA: | 3.01 | Buy |
200-day EMA: | 2.6 | Buy |
Zevra Therapeutics Earnings Growth & ZVRA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.75 per share, and an increase next year of $1.62 per share.
Xeris Biopharma Holdings Earnings Growth & XERS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.13 per share, and an increase next year of $0.06 per share.
Zevra Therapeutics Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Xeris Biopharma Holdings Technical Analysis
Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |